17 October 2017
WESTCOUNTRY PROJECT TO PREVENT CEREBRAL PALSY IN PREMATURE BABIES WINS ‘SCALING UP’ FUNDING
Developed in maternity units across the West of England, the ‘PReCePT’ project has been selected by the Health Foundation to be part of an ambitious £3.5 million improvement programme.
The Scaling Up Improvement programme is supporting seven projects in the UK to take their proven health care interventions and approaches and make them work at larger scale to have a positive impact on patient outcomes.
PReCePT, which stands for the Prevention of Cerebral Palsy in PreTerm Labour, has been designed to help reduce cerebral palsy in babies by administering magnesium sulphate (MgSO4) to mothers during preterm labour, at a cost of around £1 per individual dose.
Preterm birth is the leading cause of brain injury and cerebral palsy, which has a lifelong impact on children and families.
NICE recommends administration of MgSO4 in preterm deliveries to substantially reduce the risk of cerebral palsy by 30%, based on evidence in support of its brain protective potential. However, the uptake of MgSO4 in the UK remains relatively low, compared with the leading countries in the developed world.
The PReCePT initiative was developed by University Hospitals Bristol NHS Foundation Trust in collaboration with the West of England Academic Health Science Network (AHSN), and co-designed with both patients and staff. The NIHR Collaboration for Leadership in Applied Health and Care (CLAHRC) West is evaluating the initiative.
Providing a comprehensive package of training and support materials, the intervention was rolled out to all five maternity units in the West of England (St Michael’s Hospital, Bristol; Gloucestershire Royal Hospital; Great Western Hospital – Swindon; Southmead Hospital – Bristol; and Royal United Hospital – Bath). It is estimated that this first phase of PReCePT has so far prevented five to ten cases of cerebral palsy across the region, representing potential lifetime healthcare savings in the region of £5 million and substantially more when including loss of productivity and social care costs over a lifetime.
As a result of the £0.5 million Scaling Up funding from the Health Foundation, support can now be provided to a further 10 hospital trusts around the country to implement PReCePT in their maternity units, covering the South, North West and South West of England, Midlands, Wales and London.
NIHR CLAHRC West will carry out a full evaluation of the wider roll-out of PReCePT and it is hoped that this will inform future spread across all maternity units. If rolled out nationally, it is estimated that up to 14,000 low birthweight babies could benefit from this intervention each year.
Dr Karen Luyt is a Consultant in Neonatal Medicine at St Michael’s Hospital, which is part of University Hospitals Bristol NHS Foundation Trust, and has been the project lead for PReCePT since it was first launched in 2014.
Dr Luyt said: “Magnesium sulphate is a very cost effective way to prevent brain injury in babies that are born early. We have already demonstrated that this evidence-based intervention can be put into practice rapidly and be sustained when supported by quality improvement (QI) methodology. Our aim with PReCePT2 is to scale up across the UK, ultimately making this potentially life changing intervention consistently available for every eligible preterm delivery.”
University Hospitals Bristol will lead this next phase to scale up PReCePT to 10 further trusts, working in partnership with a wide range of organisations, including:
- NIHR CLAHRC West (evaluation partner)
- People in Health West of England (patient and public involvement)
- West of England AHSN (training and support)
- Innovation Agency – AHSN for the North West Coast (supporting rollout to maternity units in the North West)
The Health Foundation’s Scaling Up programme will run for two and a half years and each project will receive up to £0.5 million of funding to put their project into practice and evaluate it.
Sarah Henderson, Associate Director from the Health Foundation said: “We are very excited to support seven outstanding project teams who have been selected because of their expertise in scaling complex improvement projects, and their ambition to achieve impact by improving care for patients.
“Working together, as part of the Scaling Up programme, we aim to make sustained improvements to health care by testing out proven interventions at a scale. We hope to see the interventions being widely adopted across the UK.”
Vanesther Rees, Communications Manager, West of England AHSN
email@example.com 0117 984 1629
Sushma Sangyam, Senior Marketing and Communications Manager
firstname.lastname@example.org 020 7257 2092
Notes to editors follow
Notes to editors
- The Health Foundation is an independent charity committed to bringing about better health and health care for people in the UK. Find out more at health.org.uk
- The West of England Academic Health Science Network (AHSN) is based in Bristol and is one of 15 AHSNs across England, established by NHS England in 2013 to spread innovation at pace and scale. As the only bodies that connect NHS and academic organisations, the third sector and industry, AHSNs are catalysts that create the right conditions to facilitate change across whole health and social care economies, with a clear focus on improving outcomes for citizens. Find out more at www.weahsn.net
- The NIHR Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West) works with its partner organisations, including local NHS and public health providers, to conduct applied health research and implement research evidence, to improve health and healthcare across the West. It undertakes applied health research projects, in collaboration with its partners across the region and nationally. The research it does must have a real-world application and fall into one of our broad thematic areas of ‘improving the management of chronic health conditions’ and ‘public health interventions and population health’.